Company Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Minerva Surgical, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

Market Closed - Nasdaq Other stock markets 03:59:45 2023-12-01 pm EST			5-day change	1st Jan Change
2.060 ^USD	+10.16%		+19.08%	-53.89%

Nov. 13	Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
Nov. 13	Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M	MT

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.

Number of employees : 174

USD in Million	2021	Weight	2022	Weight	Delta
Abnormal Uterine Bleeding Therapeutic Devices 100.0 %	52	100.0 %	50	100.0 %	-3.47%

USD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	52	100.0 %	50	100.0 %	-3.47%

Managers	Title	Age	Since
Todd Usen CEO	Chief Executive Officer	-	Jan. 01
Joel R. Jung DFI	Director of Finance/CFO	65	2020
Eugene V. Skalnyi CTO	Chief Tech/Sci/R&D Officer	57	2010
Dominique J. Filloux COO	Chief Operating Officer	61	2009
Caroline Corne IRC	Investor Relations Contact	-	-
Joanne Long AUD	Comptroller/Controller/Auditor	-	2021
Wendy Bowman HRO	Human Resources Officer	-	2014

Members of the board	Title	Age	Since
Uri Geiger CHM	Chairman	55	Feb. 08
Ali Behbahani BRD	Director/Board Member	46	2011
Derrick Sung BRD	Director/Board Member	50	2022
Niquette L. Hunt BRD	Director/Board Member	58	2021
Todd Usen CEO	Chief Executive Officer	-	Jan. 01
Catherine Coste BRD	Director/Board Member	57	2021
Daniel Cohen BRD	Director/Board Member	-	Feb. 28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	8,878,582	2,731,338 ( 30.76 %)	0	30.76 %

Name	Equities	%	Valuation
A.M. Accelmed Management (2009) Ltd. 68.81 %	6,109,482	68.81 %	20 M $
NEA Management Co. LLC 19.39 %	1,721,853	19.39 %	6 M $
CVF LLC 1.273 %	112,985	1.273 %	364 942 $
Versant Venture Management LLC 0.9679 %	85,938	0.9679 %	277 580 $
Dominique J. Filloux 0.1400 %	12,431	0.1400 %	40 152 $
Geode Capital Management LLC 0.1156 %	10,267	0.1156 %	33 162 $
Ross Jaffe 0.0744 %	6,605	0.0744 %	21 334 $
Catherine Coste 0.0669 %	5,940	0.0669 %	19 186 $
Frank, Rimerman Advisors LLC 0.0626 %	5,556	0.0626 %	17 946 $
Joel R. Jung 0.0571 %	5,072	0.0571 %	16 383 $

Minerva Surgical, Inc.

101 Saginaw Drive

94063, Redwood City

http://minervasurgical.com

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.060USD

Average target price

3.000USD

Spread / Average Target

+45.63%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
MINERVA SURGICAL, INC.	-53.89%	18 M $
STRYKER CORPORATION	+21.80%	113 B $
SMITH & NEPHEW PLC	-6.67%	11 448 M $
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-47.38%	9 012 M $
INSPIRE MEDICAL SYSTEMS, INC.	-39.76%	4 479 M $
GLAUKOS CORPORATION	+49.11%	3 176 M $
AXONICS, INC.	-8.06%	2 913 M $
ENOVIS CORPORATION	-4.76%	2 783 M $
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+7.49%	2 653 M $
DOUBLE MEDICAL TECHNOLOGY INC.	+19.37%	2 356 M $

Medical Devices & Implants